Published in J Clin Endocrinol Metab on November 01, 1978
Androgen production in a patient with Klinefelter's syndrome and choriocarcinoma. Br Med J (1980) 0.75
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med (1985) 2.49
Atrial natriuretic peptide after myocardial infarction. Am Heart J (1989) 2.05
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab (1995) 1.74
Accurate measurements of the lower leg length and the ulnar length and its application in short term growth measurement. Growth (1983) 1.71
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest (2000) 1.70
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand (1980) 1.45
Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine. J Nucl Med (1991) 1.42
[Systemic mastocytosis as a cause of osteoporosis]. Ned Tijdschr Geneeskd (1996) 1.40
Glycyrrhetinic acid and potentiation of hydrocortisone activity in skin. Lancet (1990) 1.39
Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) (2001) 1.37
Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat (1991) 1.23
Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet (1985) 1.17
Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. J Clin Endocrinol Metab (1989) 1.15
Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb (1994) 1.14
Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest (1983) 1.13
A method of preparing adrenal cell suspensions and its applicability to the in vitro study of adrenal metabolism. Endocrinology (1968) 1.13
Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat (1992) 1.07
Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta (1982) 1.05
Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. Am J Cardiol (1975) 1.03
Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res (1991) 1.03
Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival. Eur J Cancer Clin Oncol (1984) 1.00
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat (1985) 0.98
Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem (1995) 0.98
Reduced imprecision of the radioenzymatic assay of plasma catecholamines by improving the stability of the internal standards. Clin Chim Acta (1986) 0.97
Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre. Eur J Nucl Med (1993) 0.96
The effect of oestrogen administration on plasma testosterone, FSH and LH levels in patients with Klinefelter's syndrome and normal men. Acta Endocrinol (Copenh) (1974) 0.96
Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study. Clin Endocrinol (Oxf) (1999) 0.94
Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism (1983) 0.94
The reliability of the measurement of plasma renin activity by radioimmunoassay. Clin Chim Acta (1975) 0.93
Homocystinuria versus Marfan's syndrome: the therapeutic relevance of the differential diagnosis. Neth J Med (1984) 0.92
Alcohol-induced Cushingoid syndrome. J R Coll Physicians Lond (1977) 0.91
The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. J Steroid Biochem Mol Biol (1991) 0.91
Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer (1992) 0.91
Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution. Osteoporos Int (2001) 0.91
Circannual cycle in plasma testosterone levels in man. J Clin Endocrinol Metab (1976) 0.91
Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate. J Urol (1999) 0.90
Determination of non-protein-bound plasma 1,25-dihydroxyvitamin D by symmetric (rate) dialysis. Anal Biochem (1998) 0.90
Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J Clin Endocrinol Metab (2000) 0.89
Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med (1992) 0.89
[Experiences with intracavernous auto-injection for the treatment of erection disorders]. Ned Tijdschr Geneeskd (1993) 0.89
Plasma testosterone profiles in Cushing's syndrome. J Clin Endocrinol Metab (1977) 0.89
Calcaneal ultrasound imaging in healthy children and adolescents: relation of the ultrasound parameters BUA and SOS to age, body weight, height, foot dimensions and pubertal stage. Osteoporos Int (2000) 0.88
Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. J Clin Endocrinol Metab (1989) 0.87
The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta (1987) 0.87
Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. Clin Chem (1991) 0.87
Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies. Endocrinology (1992) 0.86
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. J Clin Oncol (1998) 0.86
Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy. N Engl J Med (1977) 0.86
Seasonal variation in serum T3 and T4 levels in man. J Clin Endocrinol Metab (1977) 0.86
Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration. Clin Endocrinol (Oxf) (1984) 0.86
Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res Treat (1993) 0.85
Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. N Engl J Med (1988) 0.85